Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Autologous CMV-specific CTLs |
| Trade Name | |
| Synonyms | Autologous cytomegalovirus-specific cytotoxic T-lymphocytes |
| Drug Descriptions |
Autologous CMV-specific CTLs are patient-derived cytotoxic T-lymphocytes (CTLs) that are reactive to cytomegalovirus (CMV), which potentially increase immune response to CMV-related tumors (PMID: 22421947). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | C116732 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Autologous CMV-specific CTLs | Autologous CMV-specific CTLs | 0 | 0 |
| Autologous CMV-specific CTLs + Temozolomide | Autologous CMV-specific CTLs Temozolomide | 0 | 1 |